Vertex Pharmaceuticals Inc VRTX:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 02/03/23 EST
301.02UNCH (UNCH)
Volume
94,692
Close
301.02quote price arrow down-2.76 (-0.91%)
Volume
1,524,971
52 week range
225.28 - 325.19
Loading...
  • Open304.56
  • Day High306.40
  • Day Low300.75
  • Prev Close303.78
  • 52 Week High325.19
  • 52 Week High Date01/31/23
  • 52 Week Low225.28
  • 52 Week Low Date02/24/22

Key Stats

  • Market Cap77.269B
  • Shares Out256.69M
  • 10 Day Average Volume1.49M
  • Dividend-
  • Dividend Yield-
  • Beta0.46
  • YTD % Change4.24

KEY STATS

  • Open304.56
  • Day High306.40
  • Day Low300.75
  • Prev Close303.78
  • 52 Week High325.19
  • 52 Week High Date01/31/23
  • 52 Week Low225.28
  • 52 Week Low Date02/24/22
  • Market Cap77.269B
  • Shares Out256.69M
  • 10 Day Average Volume1.49M
  • Dividend-
  • Dividend Yield-
  • Beta0.46
  • YTD % Change4.24

RATIOS/PROFITABILITY

  • EPS (TTM)12.67
  • P/E (TTM)23.76
  • Fwd P/E (NTM)19.72
  • EBITDA (TTM)4.308B
  • ROE (TTM)29.02%
  • Revenue (TTM)8.701B
  • Gross Margin (TTM)88.00%
  • Net Margin (TTM)37.62%
  • Debt To Equity (MRQ)3.39%

EVENTS

  • Earnings Date02/07/2023
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Vertex Pharmaceuticals Inc

 

Profile

MORE
Vertex Pharmaceuticals Incorporated is a global biotechnology company. The Company is focused on developing medicines that treat the underlying cause of cystic fibrosis (CF) and it has several ongoing clinical and research programs to advance and extend treatment of CF. The Company's marketed medicines are TRIKAFTA/KAFTRIO (elexacaftor/tezacaftor/ivacaftor and ivacaftor), SYMDEKO/SYMKEVI (tezacaftor/ivacaftor and ivacaftor), ORKAMBI (lumacaftor/ivacaftor) and KALYDECO...
Jeffrey Leiden M.D., Ph.D.
Executive Chairman of the Board
Reshma Kewalramani
President, Chief Executive Officer, Director
Stuart Arbuckle
Chief Operating Officer, Executive Vice President
Charles Wagner Jr.
Chief Financial Officer, Executive Vice President
Carmen Bozic M.D.
Executive Vice President - Global Medicines Development and Medical Affairs, Chief Medical Officer
Address
50 Northern Avenue
Boston, MA
02210
United States

Top Peers

SYMBOLLASTCHG%CHG
ZTS
Zoetis Inc
167.80-3.20-1.87%
TAK
Takeda Pharmaceutical Co Ltd
15.97+0.23+1.46%
HZNP
Horizon Therapeutics PLC
109.68-0.11-0.10%
GILD
Gilead Sciences Inc
84.50+3.11+3.82%
SGEN
Seagen Inc
138.00-1.43-1.03%